209 related articles for article (PubMed ID: 12372943)
21. Anemia of chronic renal failure: treatment with erythropoietin.
Navarro M; Alonso A; Avilla JM; Espinosa L
Child Nephrol Urol; 1991; 11(3):146-51. PubMed ID: 1777893
[TBL] [Abstract][Full Text] [Related]
22. Intraperitoneal administration of recombinant human erythropoietin.
Frenken LA; Struijk DG; Coppens PJ; Tiggeler RG; Krediet RT; Koene RA
Perit Dial Int; 1992; 12(4):378-83. PubMed ID: 1420497
[TBL] [Abstract][Full Text] [Related]
23. Protocolized anemia management with erythropoietin in hemodialysis patients: a randomized controlled trial.
Brimble KS; Rabbat CG; McKenna P; Lambert K; Carlisle EJ
J Am Soc Nephrol; 2003 Oct; 14(10):2654-61. PubMed ID: 14514745
[TBL] [Abstract][Full Text] [Related]
24. Factors contributing to higher hematocrit levels in hemodialysis patients not receiving recombinant human erythropoietin.
Takeda A; Toda T; Shinohara S; Mogi Y; Matsui N
Am J Kidney Dis; 2002 Jul; 40(1):104-9. PubMed ID: 12087567
[TBL] [Abstract][Full Text] [Related]
25. Effect of low dose recombinant human omega erythropoietin (rHuEPO) on anaemia in patients on hemodialysis.
Acharya VN; Sinha DK; Almeida AF; Pathare AV
J Assoc Physicians India; 1995 Aug; 43(8):539-42. PubMed ID: 8772973
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of anemia in patients with chronic renal insufficiency undergoing hemodialysis with recombinant human erythropoietin: 12 months' experience].
de Sousa FT; Prata MM; Barbas JV; dos Santos JP
Acta Med Port; 1990; 3(6):347-52. PubMed ID: 2089856
[TBL] [Abstract][Full Text] [Related]
27. Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin.
Fishbane S; Berns JS
Kidney Int; 2005 Sep; 68(3):1337-43. PubMed ID: 16105069
[TBL] [Abstract][Full Text] [Related]
28. Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial.
Eschbach JW; Abdulhadi MH; Browne JK; Delano BG; Downing MR; Egrie JC; Evans RW; Friedman EA; Graber SE; Haley NR
Ann Intern Med; 1989 Dec; 111(12):992-1000. PubMed ID: 2688507
[TBL] [Abstract][Full Text] [Related]
29. Influence of thalassemia on the response to recombinant human erythropoietin in dialysis patients.
Cheng IK; Lu HB; Wei DC; Cheng SW; Chan CY; Lee FC
Am J Nephrol; 1993; 13(2):142-8. PubMed ID: 8342581
[TBL] [Abstract][Full Text] [Related]
30. Influence of relative hypoparathyroidism on the responsiveness to recombinant human erythropoietin in hemodialysis patients.
Hsu SP; Peng YS; Pai MF; Hung KY; Tsai TJ
Blood Purif; 2003; 21(3):220-4. PubMed ID: 12784047
[TBL] [Abstract][Full Text] [Related]
31. Erythropoietin with oral iron in peritoneal and hemodialysis patients. A comparison in an inner city population.
Raja R; Bloom E; Goldstein M; Johnson R
ASAIO J; 1993; 39(3):M578-80. PubMed ID: 8268603
[TBL] [Abstract][Full Text] [Related]
32. High-calorie supplementation increases serum leptin levels and improves response to rHuEPO in long-term hemodialysis patients.
Hung SC; Tung TY; Yang CS; Tarng DC
Am J Kidney Dis; 2005 Jun; 45(6):1073-83. PubMed ID: 15957137
[TBL] [Abstract][Full Text] [Related]
33. [Darbepoetin-alfa treatment of anemia secondary to chronic renal failure in dialysis patients: Results of a French multicenter study].
Kessler M; Hannedouche T; Fitte H; Cayotte JL; Urena P; Réglier JC;
Nephrol Ther; 2006 Sep; 2(4):191-9. PubMed ID: 16966064
[TBL] [Abstract][Full Text] [Related]
34. The haematopoietic effect of recombinant human erythropoietin in haemodialysis is independent of the mode of administration (i.v. or s.c.).
De Schoenmakere G; Lameire N; Dhondt A; Van Loo A; Van der Goten J; Duym P; Vanholder R
Nephrol Dial Transplant; 1998 Jul; 13(7):1770-5. PubMed ID: 9681726
[TBL] [Abstract][Full Text] [Related]
35. Therapy of renal anemia in children and adolescents with recombinant human erythropoietin (rHuEPO).
Campos A; Garin EH
Clin Pediatr (Phila); 1992 Feb; 31(2):94-9. PubMed ID: 1544282
[TBL] [Abstract][Full Text] [Related]
36. Conventional versus ultrapure dialysate for lowering serum lipoprotein(a) levels in patients on long-term hemodialysis: a randomized trial.
Tao J; Sun Y; Li X; Li H; Liu S; Wen Y; Duan L; Li Y; Li X
Int J Artif Organs; 2010 May; 33(5):290-6. PubMed ID: 20593350
[TBL] [Abstract][Full Text] [Related]
37. Impact of recombinant human erythropoietin treatment on left ventricular hypertrophy and cardiac function in dialysis patients.
Massimetti C; Pontillo D; Feriozzi S; Costantini S; Capezzuto A; Ancarani E
Blood Purif; 1998; 16(6):317-24. PubMed ID: 10343078
[TBL] [Abstract][Full Text] [Related]
38. Epoetin omega for treatment of anemia in maintenance hemodialysis patients.
Sikole A; Spasovski G; Zafirov D; Polenakovic M
Clin Nephrol; 2002 Mar; 57(3):237-45. PubMed ID: 11924756
[TBL] [Abstract][Full Text] [Related]
39. Correction of copper deficiency improves erythropoietin unresponsiveness in hemodialysis patients with anemia.
Higuchi T; Matsukawa Y; Okada K; Oikawa O; Yamazaki T; Ohnishi Y; Fujita T; Fukuda N; Soma M; Matsumoto K
Intern Med; 2006; 45(5):271-3. PubMed ID: 16595992
[TBL] [Abstract][Full Text] [Related]
40. [Reticulocyte response after immediate withdrawal of recombinant human erythropoietin in chronic hemodialysis patients].
Caramelo C; Soto C; Neira F; López MD; Jiménez S; Albalate M; de Oña R; Llamas P; Deudero JJ
Nefrologia; 2004; 24(4):351-6. PubMed ID: 15455495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
